Literature DB >> 30153321

Obese Breast Cancer Patients and Survivors: Management Considerations.

Jennifer Y Sheng, Dipali Sharma, Gerald Jerome, Cesar Augusto Santa-Maria.   

Abstract

Excess body weight is a significant risk factor for many cancers, especially breast cancer. Patients with breast cancer or those with a history of the disease who are overweight or obese have an increased risk of therapy-related morbidity, recurrence, and breast cancer-related mortality. Obesity may also affect quality-of-life factors for survivors, including sexual dysfunction, neuropathy, cardiotoxicity, chronic fatigue, and lymphedema. Most cancer guidelines recommend that breast cancer survivors who are overweight or obese lose weight and that those with a normal body mass index (BMI) maintain a stable body weight. The cornerstone of interventions to treat or prevent obesity is lifestyle modification with diet and exercise; however, integrating these things into clinical practice is challenging. This article will present feasible weight loss interventions, and will discuss practical implications of ongoing chemotherapy and endocrine therapy with regard to weight gain, and the impact of obesity on therapy-related conditions during breast cancer survivorship.

Entities:  

Mesh:

Year:  2018        PMID: 30153321      PMCID: PMC9337744     

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.533


  66 in total

Review 1.  Dietary Guidelines for Breast Cancer Patients: A Critical Review.

Authors:  Ana Teresa Limon-Miro; Veronica Lopez-Teros; Humberto Astiazaran-Garcia
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

2.  Adult weight change and risk of postmenopausal breast cancer.

Authors:  A Heather Eliassen; Graham A Colditz; Bernard Rosner; Walter C Willett; Susan E Hankinson
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

3.  Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up.

Authors:  Martina E Schmidt; Joachim Wiskemann; Andreas Schneeweiss; Karin Potthoff; Cornelia M Ulrich; Karen Steindorf
Journal:  Int J Cancer       Date:  2017-11-13       Impact factor: 7.396

4.  Body mass index and breast cancer treatment-related lymphedema.

Authors:  Sheila H Ridner; Mary S Dietrich; Bob R Stewart; Jane M Armer
Journal:  Support Care Cancer       Date:  2011-01-16       Impact factor: 3.603

Review 5.  Body mass index and aromatase inhibitors: a step forward in individualizing therapy for breast cancer patients?

Authors:  Agnieszka Słowik; Paulina A Frączek; Krzysztof Krzemieniecki
Journal:  Expert Rev Anticancer Ther       Date:  2016-06-07       Impact factor: 4.512

6.  Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.

Authors:  Jennifer K Litton; Ana M Gonzalez-Angulo; Carla L Warneke; Aman U Buzdar; Shu-Wan Kau; Melissa Bondy; Somdat Mahabir; Gabriel N Hortobagyi; Abenaa M Brewster
Journal:  J Clin Oncol       Date:  2008-09-01       Impact factor: 44.544

7.  Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial.

Authors:  John P Pierce; Loki Natarajan; Bette J Caan; Barbara A Parker; E Robert Greenberg; Shirley W Flatt; Cheryl L Rock; Sheila Kealey; Wael K Al-Delaimy; Wayne A Bardwell; Robert W Carlson; Jennifer A Emond; Susan Faerber; Ellen B Gold; Richard A Hajek; Kathryn Hollenbach; Lovell A Jones; Njeri Karanja; Lisa Madlensky; James Marshall; Vicky A Newman; Cheryl Ritenbaugh; Cynthia A Thomson; Linda Wasserman; Marcia L Stefanick
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

8.  Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.

Authors:  Elizabeth J Folkerd; J Michael Dixon; Lorna Renshaw; Roger P A'Hern; Mitch Dowsett
Journal:  J Clin Oncol       Date:  2012-07-16       Impact factor: 44.544

9.  Predictors and course of chronic fatigue in long-term breast cancer survivors.

Authors:  Kristin Valborg Reinertsen; Milada Cvancarova; Jon H Loge; Hege Edvardsen; Erik Wist; Sophie D Fosså
Journal:  J Cancer Surviv       Date:  2010-09-23       Impact factor: 4.442

10.  Change in Physical Activity During a Weight Management Intervention for Breast Cancer Survivors: Association with Weight Outcomes.

Authors:  Tera L Fazzino; Carol Fabian; Christie A Befort
Journal:  Obesity (Silver Spring)       Date:  2017-11       Impact factor: 5.002

View more
  14 in total

1.  Impact of Diabetes on the Symptoms of Breast Cancer Survivors.

Authors:  Susan Storey; Andrea Cohee; Wambui G Gathirua-Mwangi; Eric Vachon; Patrick Monahan; Julie Otte; Timothy E Stump; David Cella; Victoria Champion
Journal:  Oncol Nurs Forum       Date:  2019-07-01       Impact factor: 2.172

2.  The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial.

Authors:  Cesar A Santa-Maria; Janelle W Coughlin; Dipali Sharma; Mary Armanios; Amanda L Blackford; Colleen Schreyer; Arlene Dalcin; Ashley Carpenter; Gerald J Jerome; Deborah K Armstrong; Madhu Chaudhry; Gary I Cohen; Roisin M Connolly; John Fetting; Robert S Miller; Karen L Smith; Claire Snyder; Andrew Wolfe; Antonio C Wolff; Chiung-Yu Huang; Lawrence J Appel; Vered Stearns
Journal:  Clin Cancer Res       Date:  2020-02-18       Impact factor: 12.531

3.  Cyclin H Regulates Lung Cancer Progression as a Carcinoma Inducer.

Authors:  Lili Mao; Xu Ling; Ji Chen
Journal:  Comput Math Methods Med       Date:  2021-03-09       Impact factor: 2.238

Review 4.  Landmark trials in the medical oncology management of early stage breast cancer.

Authors:  Whitney Hensing; Cesar A Santa-Maria; Lindsay L Peterson; Jennifer Y Sheng
Journal:  Semin Oncol       Date:  2020-08-30       Impact factor: 4.929

5.  Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer.

Authors:  Eric Xie; Maya M Lapinski; Sarah Talamantes; Bareng A S Nonyane; Maria Cristina Figueroa Magalhães; Kala Visvanathan; Antonio C Wolff; Cesar A Santa-Maria
Journal:  Breast Cancer Res Treat       Date:  2020-11-13       Impact factor: 4.624

Review 6.  Breast Cancer Survivorship, Quality of Life, and Late Toxicities.

Authors:  Simone Nardin; Edoardo Mora; Feba Mariam Varughese; Francesca D'Avanzo; Ajay Ram Vachanaram; Valentina Rossi; Chiara Saggia; Sara Rubinelli; Alessandra Gennari
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

7.  Perspective: Towards Personalised Metabolic Coaching in Cancer.

Authors:  T Van Soom; W Tjalma; S El Bakkali; H Verbelen; N Gebruers; E van Breda
Journal:  Facts Views Vis Obgyn       Date:  2018-09

8.  Heterogeneity of endometriosis lesions requires individualisation of diagnosis and treatment and a different approach to research and evidence based medicine.

Authors:  P R Koninckx; A Ussia; L Adamyan; A Wattiez; V Gomel; D C Martin
Journal:  Facts Views Vis Obgyn       Date:  2019-03

9.  Innovating and expanding weight loss strategies for breast cancer survivors.

Authors:  Jennifer Y Sheng; Vered Stearns
Journal:  Oncotarget       Date:  2021-03-16

10.  Excess Body Weight and Cancer-Related Fatigue, Systemic Inflammation, and Serum Lipids in Breast Cancer Survivors.

Authors:  Julia E Inglis; Amber S Kleckner; Po-Ju Lin; Nikesha J Gilmore; Eva Culakova; Amy C VanderWoude; Karen M Mustian; I Diana Fernandez; Richard F Dunne; Jeremy Deutsch; Luke J Peppone
Journal:  Nutr Cancer       Date:  2020-08-19       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.